| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| muscle organ development | 5 out of 37 genes, 13.5% | 6 out of 533 genes, 1.1% | 7.059015e-06 |
| striated muscle tissue development | 4 out of 37 genes, 10.8% | 5 out of 533 genes, 0.9% | 9.435801e-05 |
| muscle cell development | 4 out of 37 genes, 10.8% | 5 out of 533 genes, 0.9% | 9.435801e-05 |
| striated muscle cell development | 4 out of 37 genes, 10.8% | 5 out of 533 genes, 0.9% | 9.435801e-05 |
| muscle tissue development | 4 out of 37 genes, 10.8% | 5 out of 533 genes, 0.9% | 9.435801e-05 |
| cellular component morphogenesis | 8 out of 37 genes, 21.6% | 25 out of 533 genes, 4.7% | 0.0001149494 |
| muscle organ morphogenesis | 3 out of 37 genes, 8.1% | 3 out of 533 genes, 0.6% | 0.0003096271 |
| cardiac muscle tissue development | 3 out of 37 genes, 8.1% | 3 out of 533 genes, 0.6% | 0.0003096271 |
| skeletal muscle fiber development | 3 out of 37 genes, 8.1% | 3 out of 533 genes, 0.6% | 0.0003096271 |
| muscle fiber development | 3 out of 37 genes, 8.1% | 3 out of 533 genes, 0.6% | 0.0003096271 |
| cardiac muscle tissue morphogenesis | 3 out of 37 genes, 8.1% | 3 out of 533 genes, 0.6% | 0.0003096271 |
| muscle tissue morphogenesis | 3 out of 37 genes, 8.1% | 3 out of 533 genes, 0.6% | 0.0003096271 |
| extracellular matrix organization | 5 out of 37 genes, 13.5% | 11 out of 533 genes, 2.1% | 0.0004194483 |
| extracellular structure organization | 5 out of 37 genes, 13.5% | 11 out of 533 genes, 2.1% | 0.0004194483 |
| muscle structure development | 5 out of 37 genes, 13.5% | 11 out of 533 genes, 2.1% | 0.0004194483 |
| cellular component assembly involved in morphogenesis | 4 out of 37 genes, 10.8% | 7 out of 533 genes, 1.3% | 0.0005962858 |
| striated muscle cell differentiation | 4 out of 37 genes, 10.8% | 7 out of 533 genes, 1.3% | 0.0005962858 |
| heart morphogenesis | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| circulatory system process | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| heart process | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| skeletal muscle tissue development | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| blood circulation | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| myofibril assembly | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| actomyosin structure organization | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| actin-myosin filament sliding | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| heart contraction | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| skeletal muscle organ development | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| actin-mediated cell contraction | 3 out of 37 genes, 8.1% | 4 out of 533 genes, 0.8% | 0.00117892 |
| cell projection organization | 7 out of 37 genes, 18.9% | 27 out of 533 genes, 5.1% | 0.001398118 |
| locomotion | 7 out of 37 genes, 18.9% | 28 out of 533 genes, 5.3% | 0.001769749 |
| muscle cell differentiation | 4 out of 37 genes, 10.8% | 9 out of 533 genes, 1.7% | 0.001938202 |
| cell development | 7 out of 37 genes, 18.9% | 29 out of 533 genes, 5.4% | 0.002214635 |
| muscle system process | 3 out of 37 genes, 8.1% | 5 out of 533 genes, 0.9% | 0.002805762 |
| muscle contraction | 3 out of 37 genes, 8.1% | 5 out of 533 genes, 0.9% | 0.002805762 |
| anatomical structure morphogenesis | 8 out of 37 genes, 21.6% | 39 out of 533 genes, 7.3% | 0.003177983 |
| response to external stimulus | 6 out of 37 genes, 16.2% | 24 out of 533 genes, 4.5% | 0.003968396 |
| chemotaxis | 5 out of 37 genes, 13.5% | 17 out of 533 genes, 3.2% | 0.004116744 |
| tissue development | 5 out of 37 genes, 13.5% | 17 out of 533 genes, 3.2% | 0.004116744 |
| taxis | 5 out of 37 genes, 13.5% | 17 out of 533 genes, 3.2% | 0.004116744 |
| striated muscle contraction | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| response to osmotic stress | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| regulation of blood pressure | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| skeletal myofibril assembly | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| skeletal muscle thin filament assembly | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| ruffle organization | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| cardiocyte differentiation | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| cardiac myofibril assembly | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| cardiac cell development | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| cardiac muscle cell differentiation | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| cardiac muscle cell development | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| cardiac muscle contraction | 2 out of 37 genes, 5.4% | 2 out of 533 genes, 0.4% | 0.004697485 |
| system development | 9 out of 37 genes, 24.3% | 51 out of 533 genes, 9.6% | 0.005078895 |
| actin filament-based movement | 3 out of 37 genes, 8.1% | 6 out of 533 genes, 1.1% | 0.005342568 |
| cellular component movement | 7 out of 37 genes, 18.9% | 35 out of 533 genes, 6.6% | 0.006979821 |
| cellular component organization | 19 out of 37 genes, 51.4% | 169 out of 533 genes, 31.7% | 0.007949977 |
| cell part morphogenesis | 5 out of 37 genes, 13.5% | 20 out of 533 genes, 3.8% | 0.008830492 |
| anatomical structure formation involved in morphogenesis | 5 out of 37 genes, 13.5% | 20 out of 533 genes, 3.8% | 0.008830492 |
| cell projection morphogenesis | 5 out of 37 genes, 13.5% | 20 out of 533 genes, 3.8% | 0.008830492 |
| organ morphogenesis | 4 out of 37 genes, 10.8% | 13 out of 533 genes, 2.4% | 0.008971003 |
| regulation of anatomical structure size | 4 out of 37 genes, 10.8% | 13 out of 533 genes, 2.4% | 0.008971003 |
| axon guidance | 4 out of 37 genes, 10.8% | 14 out of 533 genes, 2.6% | 0.01193706 |
| cardiovascular system development | 4 out of 37 genes, 10.8% | 14 out of 533 genes, 2.6% | 0.01193706 |
| circulatory system development | 4 out of 37 genes, 10.8% | 14 out of 533 genes, 2.6% | 0.01193706 |
| fertilization | 2 out of 37 genes, 5.4% | 3 out of 533 genes, 0.6% | 0.0134732 |
| muscle filament sliding | 2 out of 37 genes, 5.4% | 3 out of 533 genes, 0.6% | 0.0134732 |
| regulation of defense response to virus | 2 out of 37 genes, 5.4% | 3 out of 533 genes, 0.6% | 0.0134732 |
| regulation of defense response to virus by virus | 2 out of 37 genes, 5.4% | 3 out of 533 genes, 0.6% | 0.0134732 |
| cell morphogenesis | 5 out of 37 genes, 13.5% | 22 out of 533 genes, 4.1% | 0.01352433 |
| neuron differentiation | 5 out of 37 genes, 13.5% | 22 out of 533 genes, 4.1% | 0.01352433 |
| organ development | 6 out of 37 genes, 16.2% | 31 out of 533 genes, 5.8% | 0.01507002 |
| regulation of cell migration | 4 out of 37 genes, 10.8% | 15 out of 533 genes, 2.8% | 0.01547201 |
| regulation of locomotion | 4 out of 37 genes, 10.8% | 15 out of 533 genes, 2.8% | 0.01547201 |
| regulation of cell motility | 4 out of 37 genes, 10.8% | 15 out of 533 genes, 2.8% | 0.01547201 |
| single-organism process | 30 out of 37 genes, 81.1% | 341 out of 533 genes, 64.0% | 0.01625809 |
| cellular component organization or biogenesis | 19 out of 37 genes, 51.4% | 180 out of 533 genes, 33.8% | 0.01696767 |
| cellular developmental process | 9 out of 37 genes, 24.3% | 61 out of 533 genes, 11.4% | 0.0172327 |
| heart development | 3 out of 37 genes, 8.1% | 9 out of 533 genes, 1.7% | 0.01937651 |
| cell projection assembly | 3 out of 37 genes, 8.1% | 9 out of 533 genes, 1.7% | 0.01937651 |
| regulation of actin filament polymerization | 3 out of 37 genes, 8.1% | 9 out of 533 genes, 1.7% | 0.01937651 |
| tissue morphogenesis | 3 out of 37 genes, 8.1% | 9 out of 533 genes, 1.7% | 0.01937651 |
| axonogenesis | 4 out of 37 genes, 10.8% | 16 out of 533 genes, 3.0% | 0.0196092 |
| neuron projection development | 4 out of 37 genes, 10.8% | 16 out of 533 genes, 3.0% | 0.0196092 |
| cell morphogenesis involved in neuron differentiation | 4 out of 37 genes, 10.8% | 16 out of 533 genes, 3.0% | 0.0196092 |
| neuron projection morphogenesis | 4 out of 37 genes, 10.8% | 16 out of 533 genes, 3.0% | 0.0196092 |
| cell motility | 4 out of 37 genes, 10.8% | 16 out of 533 genes, 3.0% | 0.0196092 |
| regulation of cellular component movement | 4 out of 37 genes, 10.8% | 16 out of 533 genes, 3.0% | 0.0196092 |
| localization of cell | 4 out of 37 genes, 10.8% | 16 out of 533 genes, 3.0% | 0.0196092 |
| anatomical structure development | 10 out of 37 genes, 27.0% | 74 out of 533 genes, 13.9% | 0.0216832 |
| regulation of response to biotic stimulus | 2 out of 37 genes, 5.4% | 4 out of 533 genes, 0.8% | 0.02576748 |
| cellular response to oxidative stress | 2 out of 37 genes, 5.4% | 4 out of 533 genes, 0.8% | 0.02576748 |
| cellular response to reactive oxygen species | 2 out of 37 genes, 5.4% | 4 out of 533 genes, 0.8% | 0.02576748 |
| innate immune response | 2 out of 37 genes, 5.4% | 4 out of 533 genes, 0.8% | 0.02576748 |
| positive regulation of lymphocyte activation | 2 out of 37 genes, 5.4% | 4 out of 533 genes, 0.8% | 0.02576748 |
| single-organism developmental process | 9 out of 37 genes, 24.3% | 65 out of 533 genes, 12.2% | 0.0257806 |
| regulation of actin polymerization or depolymerization | 3 out of 37 genes, 8.1% | 10 out of 533 genes, 1.9% | 0.02636515 |
| regulation of actin filament length | 3 out of 37 genes, 8.1% | 10 out of 533 genes, 1.9% | 0.02636515 |
| regulation of protein polymerization | 3 out of 37 genes, 8.1% | 10 out of 533 genes, 1.9% | 0.02636515 |
| response to stimulus | 18 out of 37 genes, 48.6% | 175 out of 533 genes, 32.8% | 0.02831683 |
| cell morphogenesis involved in differentiation | 4 out of 37 genes, 10.8% | 18 out of 533 genes, 3.4% | 0.02979431 |
| cell differentiation | 8 out of 37 genes, 21.6% | 56 out of 533 genes, 10.5% | 0.03022868 |
| neurogenesis | 5 out of 37 genes, 13.5% | 27 out of 533 genes, 5.1% | 0.03202095 |
| generation of neurons | 5 out of 37 genes, 13.5% | 27 out of 533 genes, 5.1% | 0.03202095 |
| regulation of response to stress | 5 out of 37 genes, 13.5% | 27 out of 533 genes, 5.1% | 0.03202095 |
| regulation of cytokine production | 3 out of 37 genes, 8.1% | 11 out of 533 genes, 2.1% | 0.03453303 |
| regulation of actin cytoskeleton organization | 3 out of 37 genes, 8.1% | 11 out of 533 genes, 2.1% | 0.03453303 |
| regulation of actin filament-based process | 3 out of 37 genes, 8.1% | 11 out of 533 genes, 2.1% | 0.03453303 |
| neuron development | 4 out of 37 genes, 10.8% | 19 out of 533 genes, 3.6% | 0.03587953 |
| positive regulation of leukocyte activation | 2 out of 37 genes, 5.4% | 5 out of 533 genes, 0.9% | 0.04107529 |
| regulation of muscle contraction | 2 out of 37 genes, 5.4% | 5 out of 533 genes, 0.9% | 0.04107529 |
| actin filament organization | 2 out of 37 genes, 5.4% | 5 out of 533 genes, 0.9% | 0.04107529 |
| positive regulation of cell activation | 2 out of 37 genes, 5.4% | 5 out of 533 genes, 0.9% | 0.04107529 |
| positive regulation of cytoskeleton organization | 2 out of 37 genes, 5.4% | 5 out of 533 genes, 0.9% | 0.04107529 |
| system process | 4 out of 37 genes, 10.8% | 20 out of 533 genes, 3.8% | 0.04264179 |
| multicellular organismal development | 9 out of 37 genes, 24.3% | 71 out of 533 genes, 13.3% | 0.04386075 |
| regulation of biological quality | 9 out of 37 genes, 24.3% | 71 out of 533 genes, 13.3% | 0.04386075 |
| regulation of cellular component size | 3 out of 37 genes, 8.1% | 12 out of 533 genes, 2.3% | 0.04386577 |
| cell adhesion | 5 out of 37 genes, 13.5% | 30 out of 533 genes, 5.6% | 0.04842287 |
| biological adhesion | 5 out of 37 genes, 13.5% | 30 out of 533 genes, 5.6% | 0.04842287 |
| response to abiotic stimulus | 4 out of 37 genes, 10.8% | 21 out of 533 genes, 3.9% | 0.05008563 |
| cellular response to stimulus | 14 out of 37 genes, 37.8% | 133 out of 533 genes, 25.0% | 0.05041355 |
| regulation of localization | 7 out of 37 genes, 18.9% | 52 out of 533 genes, 9.8% | 0.05701904 |
| response to reactive oxygen species | 2 out of 37 genes, 5.4% | 6 out of 533 genes, 1.1% | 0.05894166 |
| response to virus | 2 out of 37 genes, 5.4% | 6 out of 533 genes, 1.1% | 0.05894166 |
| negative regulation of actin filament depolymerization | 2 out of 37 genes, 5.4% | 6 out of 533 genes, 1.1% | 0.05894166 |
| negative regulation of actin filament polymerization | 2 out of 37 genes, 5.4% | 6 out of 533 genes, 1.1% | 0.05894166 |
| actin filament capping | 2 out of 37 genes, 5.4% | 6 out of 533 genes, 1.1% | 0.05894166 |
| regulation of muscle system process | 2 out of 37 genes, 5.4% | 6 out of 533 genes, 1.1% | 0.05894166 |
| single-organism cellular process | 27 out of 37 genes, 73.0% | 320 out of 533 genes, 60.0% | 0.06575293 |
| cellular lipid metabolic process | 3 out of 37 genes, 8.1% | 14 out of 533 genes, 2.6% | 0.06589706 |
| cell migration | 3 out of 37 genes, 8.1% | 15 out of 533 genes, 2.8% | 0.07850332 |
| actin cytoskeleton organization | 3 out of 37 genes, 8.1% | 15 out of 533 genes, 2.8% | 0.07850332 |
| regulation of protein complex assembly | 3 out of 37 genes, 8.1% | 15 out of 533 genes, 2.8% | 0.07850332 |
| negative regulation of cellular component organization | 3 out of 37 genes, 8.1% | 15 out of 533 genes, 2.8% | 0.07850332 |
| regulation of immune effector process | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| inflammatory response | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| regulation of lipid metabolic process | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| regulation of actin filament depolymerization | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| epithelial cell differentiation | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| negative regulation of protein polymerization | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| negative regulation of protein complex disassembly | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| regulation of lymphocyte activation | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| negative regulation of protein depolymerization | 2 out of 37 genes, 5.4% | 7 out of 533 genes, 1.3% | 0.07895741 |
| defense response | 3 out of 37 genes, 8.1% | 16 out of 533 genes, 3.0% | 0.09209427 |
| regulation of cytoskeleton organization | 3 out of 37 genes, 8.1% | 16 out of 533 genes, 3.0% | 0.09209427 |
| response to growth factor stimulus | 3 out of 37 genes, 8.1% | 16 out of 533 genes, 3.0% | 0.09209427 |
| cellular response to growth factor stimulus | 3 out of 37 genes, 8.1% | 16 out of 533 genes, 3.0% | 0.09209427 |
| nervous system development | 5 out of 37 genes, 13.5% | 36 out of 533 genes, 6.8% | 0.09410206 |
| developmental process | 10 out of 37 genes, 27.0% | 94 out of 533 genes, 17.6% | 0.09565939 |
| regulation of immune system process | 4 out of 37 genes, 10.8% | 26 out of 533 genes, 4.9% | 0.09734053 |
| blood vessel development | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| vasculature development | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| regulation of leukocyte activation | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| fatty acid metabolic process | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| response to oxidative stress | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| negative regulation of protein complex assembly | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| regulation of cell activation | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| negative regulation of cytoskeleton organization | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| regulation of protein depolymerization | 2 out of 37 genes, 5.4% | 8 out of 533 genes, 1.5% | 0.1007553 |
| regulation of developmental process | 5 out of 37 genes, 13.5% | 37 out of 533 genes, 6.9% | 0.1033688 |
| cellular response to chemical stimulus | 6 out of 37 genes, 16.2% | 48 out of 533 genes, 9.0% | 0.1035403 |
| regulation of cellular component biogenesis | 3 out of 37 genes, 8.1% | 17 out of 533 genes, 3.2% | 0.1066053 |
| response to oxygen-containing compound | 4 out of 37 genes, 10.8% | 27 out of 533 genes, 5.1% | 0.1087005 |
| response to chemical stimulus | 8 out of 37 genes, 21.6% | 72 out of 533 genes, 13.5% | 0.109728 |
| regulation of multicellular organismal process | 6 out of 37 genes, 16.2% | 49 out of 533 genes, 9.2% | 0.1120085 |
| endocytosis | 2 out of 37 genes, 5.4% | 9 out of 533 genes, 1.7% | 0.1240064 |
| negative regulation of organelle organization | 2 out of 37 genes, 5.4% | 9 out of 533 genes, 1.7% | 0.1240064 |
| regulation of protein complex disassembly | 2 out of 37 genes, 5.4% | 9 out of 533 genes, 1.7% | 0.1240064 |
| response to other organism | 2 out of 37 genes, 5.4% | 9 out of 533 genes, 1.7% | 0.1240064 |
| organonitrogen compound catabolic process | 5 out of 37 genes, 13.5% | 40 out of 533 genes, 7.5% | 0.133838 |
| single-multicellular organism process | 9 out of 37 genes, 24.3% | 88 out of 533 genes, 16.5% | 0.137207 |
| actin filament-based process | 3 out of 37 genes, 8.1% | 19 out of 533 genes, 3.6% | 0.138109 |
| cellular response to oxygen-containing compound | 3 out of 37 genes, 8.1% | 19 out of 533 genes, 3.6% | 0.138109 |
| homeostatic process | 4 out of 37 genes, 10.8% | 30 out of 533 genes, 5.6% | 0.1461879 |
| nuclear division | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| DNA packaging | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| immune response | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| mitosis | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| response to biotic stimulus | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| positive regulation of organelle organization | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| positive regulation of cell migration | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| positive regulation of locomotion | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| regulation of multi-organism process | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| organelle fission | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| positive regulation of cell motility | 2 out of 37 genes, 5.4% | 10 out of 533 genes, 1.9% | 0.1484167 |
| cellular membrane organization | 3 out of 37 genes, 8.1% | 20 out of 533 genes, 3.8% | 0.1549562 |
| membrane organization | 3 out of 37 genes, 8.1% | 20 out of 533 genes, 3.8% | 0.1549562 |
| lipid metabolic process | 3 out of 37 genes, 8.1% | 21 out of 533 genes, 3.9% | 0.1724346 |
| M phase of mitotic cell cycle | 2 out of 37 genes, 5.4% | 11 out of 533 genes, 2.1% | 0.1737242 |
| positive regulation of immune system process | 2 out of 37 genes, 5.4% | 11 out of 533 genes, 2.1% | 0.1737242 |
| sexual reproduction | 2 out of 37 genes, 5.4% | 11 out of 533 genes, 2.1% | 0.1737242 |
| monocarboxylic acid metabolic process | 2 out of 37 genes, 5.4% | 11 out of 533 genes, 2.1% | 0.1737242 |
| positive regulation of multicellular organismal process | 2 out of 37 genes, 5.4% | 11 out of 533 genes, 2.1% | 0.1737242 |
| positive regulation of cellular component movement | 2 out of 37 genes, 5.4% | 11 out of 533 genes, 2.1% | 0.1737242 |
| epithelium development | 2 out of 37 genes, 5.4% | 11 out of 533 genes, 2.1% | 0.1737242 |
| DNA conformation change | 2 out of 37 genes, 5.4% | 11 out of 533 genes, 2.1% | 0.1737242 |
| multicellular organismal process | 9 out of 37 genes, 24.3% | 93 out of 533 genes, 17.4% | 0.1771824 |
| purine nucleoside catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| nucleoside triphosphate catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| purine nucleoside triphosphate catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| nucleoside catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| ribonucleoside triphosphate catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| purine ribonucleoside triphosphate catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| ribonucleoside catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| purine ribonucleoside catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| glycosyl compound catabolic process | 4 out of 37 genes, 10.8% | 33 out of 533 genes, 6.2% | 0.1881491 |
| regulation of organelle organization | 3 out of 37 genes, 8.1% | 22 out of 533 genes, 4.1% | 0.19047 |
| response to inorganic substance | 2 out of 37 genes, 5.4% | 12 out of 533 genes, 2.3% | 0.1996958 |
| regulation of defense response | 2 out of 37 genes, 5.4% | 12 out of 533 genes, 2.3% | 0.1996958 |
| neurotrophin signaling pathway | 2 out of 37 genes, 5.4% | 12 out of 533 genes, 2.3% | 0.1996958 |
| neurotrophin TRK receptor signaling pathway | 2 out of 37 genes, 5.4% | 12 out of 533 genes, 2.3% | 0.1996958 |
| purine nucleotide catabolic process | 4 out of 37 genes, 10.8% | 34 out of 533 genes, 6.4% | 0.2029737 |
| purine ribonucleotide catabolic process | 4 out of 37 genes, 10.8% | 34 out of 533 genes, 6.4% | 0.2029737 |
| nucleotide catabolic process | 4 out of 37 genes, 10.8% | 34 out of 533 genes, 6.4% | 0.2029737 |
| ribonucleotide catabolic process | 4 out of 37 genes, 10.8% | 34 out of 533 genes, 6.4% | 0.2029737 |
| organophosphate catabolic process | 4 out of 37 genes, 10.8% | 34 out of 533 genes, 6.4% | 0.2029737 |
| purine-containing compound catabolic process | 4 out of 37 genes, 10.8% | 34 out of 533 genes, 6.4% | 0.2029737 |
| nucleoside phosphate catabolic process | 4 out of 37 genes, 10.8% | 34 out of 533 genes, 6.4% | 0.2029737 |
| regulation of signal transduction | 6 out of 37 genes, 16.2% | 58 out of 533 genes, 10.9% | 0.2032851 |
| response to wounding | 3 out of 37 genes, 8.1% | 23 out of 533 genes, 4.3% | 0.2089889 |
| regulation of response to stimulus | 7 out of 37 genes, 18.9% | 71 out of 533 genes, 13.3% | 0.2091941 |
| vesicle-mediated transport | 4 out of 37 genes, 10.8% | 35 out of 533 genes, 6.6% | 0.2181577 |
| carbohydrate derivative catabolic process | 4 out of 37 genes, 10.8% | 35 out of 533 genes, 6.6% | 0.2181577 |
| regulation of I-kappaB kinase/NF-kappaB cascade | 2 out of 37 genes, 5.4% | 13 out of 533 genes, 2.4% | 0.2261252 |
| single organism reproductive process | 2 out of 37 genes, 5.4% | 13 out of 533 genes, 2.4% | 0.2261252 |
| signal transduction | 9 out of 37 genes, 24.3% | 99 out of 533 genes, 18.6% | 0.2318747 |
| regulation of transport | 4 out of 37 genes, 10.8% | 36 out of 533 genes, 6.8% | 0.2336646 |
| cellular component assembly | 7 out of 37 genes, 18.9% | 74 out of 533 genes, 13.9% | 0.2419581 |
| positive regulation of transport | 2 out of 37 genes, 5.4% | 14 out of 533 genes, 2.6% | 0.2528299 |
| negative regulation of developmental process | 2 out of 37 genes, 5.4% | 14 out of 533 genes, 2.6% | 0.2528299 |
| regulation of protein transport | 2 out of 37 genes, 5.4% | 14 out of 533 genes, 2.6% | 0.2528299 |
| cell division | 2 out of 37 genes, 5.4% | 14 out of 533 genes, 2.6% | 0.2528299 |
| immune system process | 4 out of 37 genes, 10.8% | 38 out of 533 genes, 7.1% | 0.2655015 |
| signaling | 9 out of 37 genes, 24.3% | 103 out of 533 genes, 19.3% | 0.2718123 |
| single organism signaling | 9 out of 37 genes, 24.3% | 103 out of 533 genes, 19.3% | 0.2718123 |
| M phase | 2 out of 37 genes, 5.4% | 15 out of 533 genes, 2.8% | 0.2796494 |
| wound healing | 2 out of 37 genes, 5.4% | 15 out of 533 genes, 2.8% | 0.2796494 |
| regulation of system process | 2 out of 37 genes, 5.4% | 15 out of 533 genes, 2.8% | 0.2796494 |
| regulation of establishment of protein localization | 2 out of 37 genes, 5.4% | 15 out of 533 genes, 2.8% | 0.2796494 |
| regulation of cellular response to stress | 2 out of 37 genes, 5.4% | 15 out of 533 genes, 2.8% | 0.2796494 |
| purine nucleoside triphosphate metabolic process | 4 out of 37 genes, 10.8% | 39 out of 533 genes, 7.3% | 0.2817589 |
| purine ribonucleoside triphosphate metabolic process | 4 out of 37 genes, 10.8% | 39 out of 533 genes, 7.3% | 0.2817589 |
| cellular response to organic substance | 4 out of 37 genes, 10.8% | 39 out of 533 genes, 7.3% | 0.2817589 |
| GTP catabolic process | 3 out of 37 genes, 8.1% | 27 out of 533 genes, 5.1% | 0.2864917 |
| guanosine-containing compound catabolic process | 3 out of 37 genes, 8.1% | 27 out of 533 genes, 5.1% | 0.2864917 |
| ribonucleoside triphosphate metabolic process | 4 out of 37 genes, 10.8% | 40 out of 533 genes, 7.5% | 0.2981946 |
| purine nucleoside metabolic process | 4 out of 37 genes, 10.8% | 40 out of 533 genes, 7.5% | 0.2981946 |
| purine ribonucleoside metabolic process | 4 out of 37 genes, 10.8% | 40 out of 533 genes, 7.5% | 0.2981946 |
| response to organic substance | 5 out of 37 genes, 13.5% | 53 out of 533 genes, 9.9% | 0.302069 |
| regulation of cell communication | 6 out of 37 genes, 16.2% | 66 out of 533 genes, 12.4% | 0.3021942 |
| cytoskeleton organization | 3 out of 37 genes, 8.1% | 28 out of 533 genes, 5.3% | 0.306393 |
| embryo development | 2 out of 37 genes, 5.4% | 16 out of 533 genes, 3.0% | 0.306443 |
| chromatin modification | 2 out of 37 genes, 5.4% | 16 out of 533 genes, 3.0% | 0.306443 |
| regulation of anatomical structure morphogenesis | 2 out of 37 genes, 5.4% | 16 out of 533 genes, 3.0% | 0.306443 |
| organelle organization | 7 out of 37 genes, 18.9% | 80 out of 533 genes, 15.0% | 0.3122883 |
| localization | 12 out of 37 genes, 32.4% | 148 out of 533 genes, 27.8% | 0.3138399 |
| cell communication | 9 out of 37 genes, 24.3% | 107 out of 533 genes, 20.1% | 0.3139695 |
| nucleoside triphosphate metabolic process | 4 out of 37 genes, 10.8% | 41 out of 533 genes, 7.7% | 0.3147735 |
| regulation of signaling | 6 out of 37 genes, 16.2% | 67 out of 533 genes, 12.6% | 0.3153257 |
| nucleobase-containing small molecule metabolic process | 5 out of 37 genes, 13.5% | 55 out of 533 genes, 10.3% | 0.3312651 |
| ribonucleoside metabolic process | 4 out of 37 genes, 10.8% | 42 out of 533 genes, 7.9% | 0.3314615 |
| apoptotic process | 2 out of 37 genes, 5.4% | 17 out of 533 genes, 3.2% | 0.333088 |
| programmed cell death | 2 out of 37 genes, 5.4% | 17 out of 533 genes, 3.2% | 0.333088 |
| negative regulation of apoptotic process | 2 out of 37 genes, 5.4% | 17 out of 533 genes, 3.2% | 0.333088 |
| chemical homeostasis | 2 out of 37 genes, 5.4% | 17 out of 533 genes, 3.2% | 0.333088 |
| cell surface receptor signaling pathway | 5 out of 37 genes, 13.5% | 56 out of 533 genes, 10.5% | 0.3460116 |
| cellular macromolecular complex assembly | 3 out of 37 genes, 8.1% | 30 out of 533 genes, 5.6% | 0.3464039 |
| GTP metabolic process | 3 out of 37 genes, 8.1% | 30 out of 533 genes, 5.6% | 0.3464039 |
| guanosine-containing compound metabolic process | 3 out of 37 genes, 8.1% | 30 out of 533 genes, 5.6% | 0.3464039 |
| purine nucleotide metabolic process | 4 out of 37 genes, 10.8% | 43 out of 533 genes, 8.1% | 0.3482253 |
| nucleoside metabolic process | 4 out of 37 genes, 10.8% | 43 out of 533 genes, 8.1% | 0.3482253 |
| purine ribonucleotide metabolic process | 4 out of 37 genes, 10.8% | 43 out of 533 genes, 8.1% | 0.3482253 |
| purine-containing compound metabolic process | 4 out of 37 genes, 10.8% | 43 out of 533 genes, 8.1% | 0.3482253 |
| glycosyl compound metabolic process | 4 out of 37 genes, 10.8% | 43 out of 533 genes, 8.1% | 0.3482253 |
| biological regulation | 21 out of 37 genes, 56.8% | 279 out of 533 genes, 52.3% | 0.3506047 |
| cell death | 2 out of 37 genes, 5.4% | 18 out of 533 genes, 3.4% | 0.3594781 |
| death | 2 out of 37 genes, 5.4% | 18 out of 533 genes, 3.4% | 0.3594781 |
| negative regulation of programmed cell death | 2 out of 37 genes, 5.4% | 18 out of 533 genes, 3.4% | 0.3594781 |
| positive regulation of cellular component organization | 2 out of 37 genes, 5.4% | 18 out of 533 genes, 3.4% | 0.3594781 |
| negative regulation of cell death | 2 out of 37 genes, 5.4% | 18 out of 533 genes, 3.4% | 0.3594781 |
| ribonucleotide metabolic process | 4 out of 37 genes, 10.8% | 44 out of 533 genes, 8.3% | 0.3650328 |
| ribose phosphate metabolic process | 4 out of 37 genes, 10.8% | 44 out of 533 genes, 8.3% | 0.3650328 |
| regulation of intracellular protein kinase cascade | 3 out of 37 genes, 8.1% | 32 out of 533 genes, 6.0% | 0.3863386 |
| regulation of cellular component organization | 4 out of 37 genes, 10.8% | 46 out of 533 genes, 8.6% | 0.3986555 |
| transmembrane receptor protein tyrosine kinase signaling pathway | 2 out of 37 genes, 5.4% | 20 out of 533 genes, 3.8% | 0.4111399 |
| regulation of protein localization | 2 out of 37 genes, 5.4% | 20 out of 533 genes, 3.8% | 0.4111399 |
| cellular component biogenesis | 7 out of 37 genes, 18.9% | 89 out of 533 genes, 16.7% | 0.4246223 |
| transport | 10 out of 37 genes, 27.0% | 132 out of 533 genes, 24.8% | 0.4359958 |
| enzyme linked receptor protein signaling pathway | 2 out of 37 genes, 5.4% | 21 out of 533 genes, 3.9% | 0.4362667 |
| response to stress | 6 out of 37 genes, 16.2% | 76 out of 533 genes, 14.3% | 0.4366901 |
| regulation of cell death | 3 out of 37 genes, 8.1% | 35 out of 533 genes, 6.6% | 0.4452889 |
| regulation of apoptotic process | 3 out of 37 genes, 8.1% | 35 out of 533 genes, 6.6% | 0.4452889 |
| regulation of programmed cell death | 3 out of 37 genes, 8.1% | 35 out of 533 genes, 6.6% | 0.4452889 |
| establishment of localization | 10 out of 37 genes, 27.0% | 133 out of 533 genes, 25.0% | 0.4469226 |
| chromatin organization | 2 out of 37 genes, 5.4% | 22 out of 533 genes, 4.1% | 0.4608464 |
| regulation of MAPK cascade | 2 out of 37 genes, 5.4% | 22 out of 533 genes, 4.1% | 0.4608464 |
| macromolecular complex assembly | 4 out of 37 genes, 10.8% | 50 out of 533 genes, 9.4% | 0.4651449 |
| regulation of cellular process | 18 out of 37 genes, 48.6% | 249 out of 533 genes, 46.7% | 0.4695219 |
| nucleoside phosphate metabolic process | 4 out of 37 genes, 10.8% | 51 out of 533 genes, 9.6% | 0.4814618 |
| nucleotide metabolic process | 4 out of 37 genes, 10.8% | 51 out of 533 genes, 9.6% | 0.4814618 |
| carbohydrate derivative metabolic process | 4 out of 37 genes, 10.8% | 51 out of 533 genes, 9.6% | 0.4814618 |
| positive regulation of response to stimulus | 3 out of 37 genes, 8.1% | 37 out of 533 genes, 6.9% | 0.4835042 |
| cell cycle phase | 2 out of 37 genes, 5.4% | 23 out of 533 genes, 4.3% | 0.4848328 |
| regulation of cellular localization | 2 out of 37 genes, 5.4% | 23 out of 533 genes, 4.3% | 0.4848328 |
| regulation of multicellular organismal development | 2 out of 37 genes, 5.4% | 23 out of 533 genes, 4.3% | 0.4848328 |
| small molecule metabolic process | 7 out of 37 genes, 18.9% | 95 out of 533 genes, 17.8% | 0.5000206 |
| regulation of biological process | 19 out of 37 genes, 51.4% | 267 out of 533 genes, 50.1% | 0.504747 |
| mitotic cell cycle | 2 out of 37 genes, 5.4% | 24 out of 533 genes, 4.5% | 0.5081886 |
| small GTPase mediated signal transduction | 2 out of 37 genes, 5.4% | 24 out of 533 genes, 4.5% | 0.5081886 |
| negative regulation of signal transduction | 2 out of 37 genes, 5.4% | 24 out of 533 genes, 4.5% | 0.5081886 |
| regulation of cell differentiation | 2 out of 37 genes, 5.4% | 24 out of 533 genes, 4.5% | 0.5081886 |
| organophosphate metabolic process | 4 out of 37 genes, 10.8% | 53 out of 533 genes, 9.9% | 0.5135742 |
| macromolecular complex subunit organization | 6 out of 37 genes, 16.2% | 82 out of 533 genes, 15.4% | 0.5170128 |
| multi-organism process | 4 out of 37 genes, 10.8% | 54 out of 533 genes, 10.1% | 0.5293313 |
| organonitrogen compound metabolic process | 5 out of 37 genes, 13.5% | 69 out of 533 genes, 12.9% | 0.5365934 |
| cell cycle | 3 out of 37 genes, 8.1% | 40 out of 533 genes, 7.5% | 0.538589 |
| cellular response to stress | 3 out of 37 genes, 8.1% | 40 out of 533 genes, 7.5% | 0.538589 |
| single-organism metabolic process | 8 out of 37 genes, 21.6% | 113 out of 533 genes, 21.2% | 0.5432396 |
| negative regulation of cellular process | 7 out of 37 genes, 18.9% | 99 out of 533 genes, 18.6% | 0.5490234 |
| cellular nitrogen compound catabolic process | 5 out of 37 genes, 13.5% | 70 out of 533 genes, 13.1% | 0.5505357 |
| heterocycle catabolic process | 5 out of 37 genes, 13.5% | 70 out of 533 genes, 13.1% | 0.5505357 |
| organic cyclic compound catabolic process | 5 out of 37 genes, 13.5% | 70 out of 533 genes, 13.1% | 0.5505357 |
| negative regulation of cell communication | 2 out of 37 genes, 5.4% | 26 out of 533 genes, 4.9% | 0.5528963 |
| negative regulation of signaling | 2 out of 37 genes, 5.4% | 26 out of 533 genes, 4.9% | 0.5528963 |
| regulation of hydrolase activity | 2 out of 37 genes, 5.4% | 26 out of 533 genes, 4.9% | 0.5528963 |
| catabolic process | 8 out of 37 genes, 21.6% | 115 out of 533 genes, 21.6% | 0.5660602 |
| regulation of phosphate metabolic process | 3 out of 37 genes, 8.1% | 42 out of 533 genes, 7.9% | 0.5735507 |
| regulation of phosphorus metabolic process | 3 out of 37 genes, 8.1% | 42 out of 533 genes, 7.9% | 0.5735507 |
| chromosome organization | 2 out of 37 genes, 5.4% | 27 out of 533 genes, 5.1% | 0.5742086 |
| protein transport | 5 out of 37 genes, 13.5% | 72 out of 533 genes, 13.5% | 0.5778778 |
| establishment of protein localization | 5 out of 37 genes, 13.5% | 73 out of 533 genes, 13.7% | 0.5912553 |
| response to endogenous stimulus | 2 out of 37 genes, 5.4% | 28 out of 533 genes, 5.3% | 0.5948098 |
| regulation of phosphorylation | 2 out of 37 genes, 5.4% | 28 out of 533 genes, 5.3% | 0.5948098 |
| negative regulation of response to stimulus | 2 out of 37 genes, 5.4% | 28 out of 533 genes, 5.3% | 0.5948098 |
| cellular catabolic process | 7 out of 37 genes, 18.9% | 104 out of 533 genes, 19.5% | 0.6077551 |
| organic acid metabolic process | 2 out of 37 genes, 5.4% | 29 out of 533 genes, 5.4% | 0.6146934 |
| protein complex assembly | 2 out of 37 genes, 5.4% | 29 out of 533 genes, 5.4% | 0.6146934 |
| carboxylic acid metabolic process | 2 out of 37 genes, 5.4% | 29 out of 533 genes, 5.4% | 0.6146934 |
| oxoacid metabolic process | 2 out of 37 genes, 5.4% | 29 out of 533 genes, 5.4% | 0.6146934 |
| positive regulation of cellular process | 7 out of 37 genes, 18.9% | 106 out of 533 genes, 19.9% | 0.6302564 |
| protein complex subunit organization | 4 out of 37 genes, 10.8% | 61 out of 533 genes, 11.4% | 0.6326234 |
| protein complex biogenesis | 2 out of 37 genes, 5.4% | 30 out of 533 genes, 5.6% | 0.6338569 |
| negative regulation of biological process | 7 out of 37 genes, 18.9% | 107 out of 533 genes, 20.1% | 0.6412675 |
| single-organism transport | 6 out of 37 genes, 16.2% | 94 out of 533 genes, 17.6% | 0.6639221 |
| positive regulation of signal transduction | 2 out of 37 genes, 5.4% | 32 out of 533 genes, 6.0% | 0.6700327 |
| positive regulation of cell communication | 2 out of 37 genes, 5.4% | 32 out of 533 genes, 6.0% | 0.6700327 |
| positive regulation of signaling | 2 out of 37 genes, 5.4% | 32 out of 533 genes, 6.0% | 0.6700327 |
| organic substance catabolic process | 7 out of 37 genes, 18.9% | 111 out of 533 genes, 20.8% | 0.683588 |
| negative regulation of gene expression | 2 out of 37 genes, 5.4% | 33 out of 533 genes, 6.2% | 0.6870569 |
| cell cycle process | 2 out of 37 genes, 5.4% | 33 out of 533 genes, 6.2% | 0.6870569 |
| cellular process | 31 out of 37 genes, 83.8% | 453 out of 533 genes, 85.0% | 0.6877117 |
| intracellular signal transduction | 3 out of 37 genes, 8.1% | 50 out of 533 genes, 9.4% | 0.6969404 |
| nucleobase-containing compound catabolic process | 4 out of 37 genes, 10.8% | 66 out of 533 genes, 12.4% | 0.6975531 |
| DNA metabolic process | 2 out of 37 genes, 5.4% | 34 out of 533 genes, 6.4% | 0.7033842 |
| positive regulation of catalytic activity | 2 out of 37 genes, 5.4% | 34 out of 533 genes, 6.4% | 0.7033842 |
| aromatic compound catabolic process | 4 out of 37 genes, 10.8% | 67 out of 533 genes, 12.6% | 0.7095738 |
| protein localization | 5 out of 37 genes, 13.5% | 84 out of 533 genes, 15.8% | 0.7230252 |
| organic substance transport | 5 out of 37 genes, 13.5% | 84 out of 533 genes, 15.8% | 0.7230252 |
| regulation of catalytic activity | 3 out of 37 genes, 8.1% | 52 out of 533 genes, 9.8% | 0.7234362 |
| positive regulation of biological process | 7 out of 37 genes, 18.9% | 116 out of 533 genes, 21.8% | 0.7322976 |
| positive regulation of protein metabolic process | 2 out of 37 genes, 5.4% | 36 out of 533 genes, 6.8% | 0.7339968 |
| phosphorus metabolic process | 4 out of 37 genes, 10.8% | 75 out of 533 genes, 14.1% | 0.7939713 |
| phosphate-containing compound metabolic process | 4 out of 37 genes, 10.8% | 75 out of 533 genes, 14.1% | 0.7939713 |
| viral reproduction | 2 out of 37 genes, 5.4% | 42 out of 533 genes, 7.9% | 0.8106252 |
| multi-organism cellular process | 2 out of 37 genes, 5.4% | 42 out of 533 genes, 7.9% | 0.8106252 |
| macromolecule localization | 5 out of 37 genes, 13.5% | 94 out of 533 genes, 17.6% | 0.8155079 |
| positive regulation of molecular function | 2 out of 37 genes, 5.4% | 43 out of 533 genes, 8.1% | 0.8213654 |
| regulation of protein metabolic process | 3 out of 37 genes, 8.1% | 61 out of 533 genes, 11.4% | 0.8216487 |
| regulation of molecular function | 3 out of 37 genes, 8.1% | 66 out of 533 genes, 12.4% | 0.8626602 |
| reproductive process | 2 out of 37 genes, 5.4% | 50 out of 533 genes, 9.4% | 0.8827907 |
| intracellular protein transport | 2 out of 37 genes, 5.4% | 51 out of 533 genes, 9.6% | 0.8898268 |
| negative regulation of macromolecule metabolic process | 2 out of 37 genes, 5.4% | 52 out of 533 genes, 9.8% | 0.8964824 |
| negative regulation of metabolic process | 2 out of 37 genes, 5.4% | 53 out of 533 genes, 9.9% | 0.9027747 |
| cellular localization | 4 out of 37 genes, 10.8% | 91 out of 533 genes, 17.1% | 0.9054935 |
| reproduction | 2 out of 37 genes, 5.4% | 55 out of 533 genes, 10.3% | 0.9143357 |
| positive regulation of metabolic process | 3 out of 37 genes, 8.1% | 75 out of 533 genes, 14.1% | 0.9166082 |
| intracellular transport | 3 out of 37 genes, 8.1% | 78 out of 533 genes, 14.6% | 0.9299233 |
| regulation of primary metabolic process | 7 out of 37 genes, 18.9% | 150 out of 533 genes, 28.1% | 0.9357803 |
| cellular protein localization | 2 out of 37 genes, 5.4% | 60 out of 533 genes, 11.3% | 0.9379856 |
| cellular macromolecule localization | 2 out of 37 genes, 5.4% | 60 out of 533 genes, 11.3% | 0.9379856 |
| establishment of localization in cell | 3 out of 37 genes, 8.1% | 82 out of 533 genes, 15.4% | 0.9447432 |
| positive regulation of cellular metabolic process | 2 out of 37 genes, 5.4% | 69 out of 533 genes, 12.9% | 0.9660931 |
| positive regulation of macromolecule metabolic process | 2 out of 37 genes, 5.4% | 70 out of 533 genes, 13.1% | 0.9683461 |
| nucleobase-containing compound metabolic process | 7 out of 37 genes, 18.9% | 165 out of 533 genes, 31.0% | 0.970712 |
| regulation of metabolic process | 7 out of 37 genes, 18.9% | 166 out of 533 genes, 31.1% | 0.9722975 |
| cellular aromatic compound metabolic process | 7 out of 37 genes, 18.9% | 169 out of 533 genes, 31.7% | 0.9766152 |
| heterocycle metabolic process | 7 out of 37 genes, 18.9% | 170 out of 533 genes, 31.9% | 0.9779176 |
| cellular nitrogen compound metabolic process | 7 out of 37 genes, 18.9% | 174 out of 533 genes, 32.6% | 0.9825135 |
| macromolecule biosynthetic process | 2 out of 37 genes, 5.4% | 79 out of 533 genes, 14.8% | 0.9831939 |
| cellular macromolecule biosynthetic process | 2 out of 37 genes, 5.4% | 79 out of 533 genes, 14.8% | 0.9831939 |
| organic cyclic compound metabolic process | 7 out of 37 genes, 18.9% | 176 out of 533 genes, 33.0% | 0.9844778 |
| nitrogen compound metabolic process | 7 out of 37 genes, 18.9% | 181 out of 533 genes, 34.0% | 0.9885598 |
| regulation of biosynthetic process | 3 out of 37 genes, 8.1% | 108 out of 533 genes, 20.3% | 0.9898033 |
| regulation of cellular metabolic process | 5 out of 37 genes, 13.5% | 148 out of 533 genes, 27.8% | 0.9902718 |
| cellular biosynthetic process | 3 out of 37 genes, 8.1% | 114 out of 533 genes, 21.4% | 0.9933246 |
| organic substance biosynthetic process | 3 out of 37 genes, 8.1% | 118 out of 533 genes, 22.1% | 0.9950007 |
| biosynthetic process | 3 out of 37 genes, 8.1% | 120 out of 533 genes, 22.5% | 0.9956823 |
| regulation of macromolecule metabolic process | 4 out of 37 genes, 10.8% | 146 out of 533 genes, 27.4% | 0.9970607 |
| regulation of macromolecule biosynthetic process | 2 out of 37 genes, 5.4% | 103 out of 533 genes, 19.3% | 0.9972416 |
| cellular metabolic process | 13 out of 37 genes, 35.1% | 297 out of 533 genes, 55.7% | 0.9973137 |
| regulation of cellular biosynthetic process | 2 out of 37 genes, 5.4% | 105 out of 533 genes, 19.7% | 0.997645 |
| primary metabolic process | 13 out of 37 genes, 35.1% | 304 out of 533 genes, 57.0% | 0.9984259 |
| regulation of nucleobase-containing compound metabolic process | 2 out of 37 genes, 5.4% | 111 out of 533 genes, 20.8% | 0.9985444 |
| metabolic process | 14 out of 37 genes, 37.8% | 321 out of 533 genes, 60.2% | 0.9987518 |
| protein metabolic process | 4 out of 37 genes, 10.8% | 158 out of 533 genes, 29.6% | 0.9988115 |
| nucleic acid metabolic process | 2 out of 37 genes, 5.4% | 114 out of 533 genes, 21.4% | 0.9988601 |
| regulation of nitrogen compound metabolic process | 2 out of 37 genes, 5.4% | 115 out of 533 genes, 21.6% | 0.9989498 |
| regulation of gene expression | 2 out of 37 genes, 5.4% | 116 out of 533 genes, 21.8% | 0.9990328 |
| organic substance metabolic process | 13 out of 37 genes, 35.1% | 311 out of 533 genes, 58.3% | 0.999106 |
| cellular protein metabolic process | 2 out of 37 genes, 5.4% | 143 out of 533 genes, 26.8% | 0.9999061 |
| macromolecule metabolic process | 6 out of 37 genes, 16.2% | 229 out of 533 genes, 43.0% | 0.9999229 |
| cellular macromolecule metabolic process | 5 out of 37 genes, 13.5% | 216 out of 533 genes, 40.5% | 0.9999534 |
| Gene Ontology term | Genes annotated to the term |
|---|
| muscle organ development | ENSAPLP00000003657, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| striated muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle cell development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| striated muscle cell development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cellular component morphogenesis | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| muscle organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle fiber development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle fiber development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000002381 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| extracellular matrix organization | ENSAPLP00000013972, ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006049, ENSAPLP00000008118 |
| extracellular structure organization | ENSAPLP00000013972, ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006049, ENSAPLP00000008118 |
| muscle structure development | ENSAPLP00000003657, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| heart morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle tissue development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000002381 |
| blood circulation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| myofibril assembly | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actomyosin structure organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-myosin filament sliding | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle organ development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000002381 |
| actin-mediated cell contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cell projection organization | ENSAPLP00000015963, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000008118, ENSAPLP00000013090 |
| locomotion | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000015503 |
| muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cell development | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| muscle system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| anatomical structure morphogenesis | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| response to external stimulus | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| chemotaxis | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| tissue development | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| taxis | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| striated muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| response to osmotic stress | ENSAPLP00000003050, ENSAPLP00000005411 |
| regulation of blood pressure | ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| skeletal muscle thin filament assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| ruffle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| cardiocyte differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| system development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based movement | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular component movement | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000004050, ENSAPLP00000002381, ENSAPLP00000015503 |
| cellular component organization | ENSAPLP00000015963, ENSAPLP00000006939, ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000003219 |
| cell part morphogenesis | ENSAPLP00000015963, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cell projection morphogenesis | ENSAPLP00000015963, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of anatomical structure size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000002381 |
| axon guidance | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cardiovascular system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| circulatory system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| fertilization | ENSAPLP00000011900, ENSAPLP00000011529 |
| muscle filament sliding | ENSAPLP00000003657, ENSAPLP00000003219 |
| regulation of defense response to virus | ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of defense response to virus by virus | ENSAPLP00000006303, ENSAPLP00000003050 |
| cell morphogenesis | ENSAPLP00000015963, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| neuron differentiation | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503 |
| organ development | ENSAPLP00000003657, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| regulation of cell migration | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of locomotion | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of cell motility | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| single-organism process | ENSAPLP00000015963, ENSAPLP00000009873, ENSAPLP00000005193, ENSAPLP00000003689, ENSAPLP00000000439, ENSAPLP00000010816, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000002553, ENSAPLP00000006303, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000011711, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000009642, ENSAPLP00000011900, ENSAPLP00000003219 |
| cellular component organization or biogenesis | ENSAPLP00000015963, ENSAPLP00000006939, ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000003219 |
| cellular developmental process | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cell projection assembly | ENSAPLP00000015963, ENSAPLP00000003050, ENSAPLP00000005411 |
| regulation of actin filament polymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| axonogenesis | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| neuron projection development | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell morphogenesis involved in neuron differentiation | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| neuron projection morphogenesis | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell motility | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000004050, ENSAPLP00000015503 |
| regulation of cellular component movement | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| localization of cell | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000004050, ENSAPLP00000015503 |
| anatomical structure development | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of response to biotic stimulus | ENSAPLP00000006303, ENSAPLP00000003050 |
| cellular response to oxidative stress | ENSAPLP00000003219, ENSAPLP00000006873 |
| cellular response to reactive oxygen species | ENSAPLP00000003219, ENSAPLP00000006873 |
| innate immune response | ENSAPLP00000005038, ENSAPLP00000006873 |
| positive regulation of lymphocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| single-organism developmental process | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament length | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein polymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| response to stimulus | ENSAPLP00000015963, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000006873, ENSAPLP00000002381, ENSAPLP00000009308, ENSAPLP00000003657, ENSAPLP00000010584, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090, ENSAPLP00000009642, ENSAPLP00000003050, ENSAPLP00000003219 |
| cell morphogenesis involved in differentiation | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell differentiation | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381, ENSAPLP00000015503 |
| neurogenesis | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503 |
| generation of neurons | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503 |
| regulation of response to stress | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of cytokine production | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament-based process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| neuron development | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090 |
| positive regulation of leukocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| regulation of muscle contraction | ENSAPLP00000003219, ENSAPLP00000013090 |
| actin filament organization | ENSAPLP00000003657, ENSAPLP00000002381 |
| positive regulation of cell activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| system process | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000002381 |
| multicellular organismal development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of biological quality | ENSAPLP00000001720, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000002381 |
| regulation of cellular component size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| cell adhesion | ENSAPLP00000003050, ENSAPLP00000008210, ENSAPLP00000003689, ENSAPLP00000000439, ENSAPLP00000006049 |
| biological adhesion | ENSAPLP00000003050, ENSAPLP00000008210, ENSAPLP00000003689, ENSAPLP00000000439, ENSAPLP00000006049 |
| response to abiotic stimulus | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000004050 |
| cellular response to stimulus | ENSAPLP00000015963, ENSAPLP00000009308, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000009642, ENSAPLP00000003219, ENSAPLP00000006873 |
| regulation of localization | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| response to reactive oxygen species | ENSAPLP00000003219, ENSAPLP00000006873 |
| response to virus | ENSAPLP00000010584, ENSAPLP00000002381 |
| negative regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| actin filament capping | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of muscle system process | ENSAPLP00000003219, ENSAPLP00000013090 |
| single-organism cellular process | ENSAPLP00000015963, ENSAPLP00000009873, ENSAPLP00000005193, ENSAPLP00000003689, ENSAPLP00000000439, ENSAPLP00000010816, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000009642, ENSAPLP00000003219 |
| cellular lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000009740 |
| cell migration | ENSAPLP00000003050, ENSAPLP00000004050, ENSAPLP00000015503 |
| actin cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of protein complex assembly | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of immune effector process | ENSAPLP00000006303, ENSAPLP00000003050 |
| inflammatory response | ENSAPLP00000003050, ENSAPLP00000005038 |
| regulation of lipid metabolic process | ENSAPLP00000003050, ENSAPLP00000011529 |
| regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| epithelial cell differentiation | ENSAPLP00000003050, ENSAPLP00000008118 |
| negative regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of lymphocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| negative regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| defense response | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| response to growth factor stimulus | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004050 |
| cellular response to growth factor stimulus | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004050 |
| nervous system development | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503 |
| developmental process | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of immune system process | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| blood vessel development | ENSAPLP00000008118, ENSAPLP00000002381 |
| vasculature development | ENSAPLP00000008118, ENSAPLP00000002381 |
| regulation of leukocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| fatty acid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| response to oxidative stress | ENSAPLP00000003219, ENSAPLP00000006873 |
| negative regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of cell activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| negative regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of developmental process | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090 |
| cellular response to chemical stimulus | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000008118, ENSAPLP00000004050 |
| regulation of cellular component biogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| response to oxygen-containing compound | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000008118 |
| response to chemical stimulus | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000013090 |
| regulation of multicellular organismal process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000013090 |
| endocytosis | ENSAPLP00000003050, ENSAPLP00000015337 |
| negative regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| response to other organism | ENSAPLP00000010584, ENSAPLP00000002381 |
| organonitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| single-multicellular organism process | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000008118 |
| homeostatic process | ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000006873 |
| nuclear division | ENSAPLP00000015963, ENSAPLP00000015503 |
| DNA packaging | ENSAPLP00000012216, ENSAPLP00000001720 |
| immune response | ENSAPLP00000005038, ENSAPLP00000006873 |
| mitosis | ENSAPLP00000015963, ENSAPLP00000015503 |
| response to biotic stimulus | ENSAPLP00000010584, ENSAPLP00000002381 |
| positive regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| positive regulation of cell migration | ENSAPLP00000013972, ENSAPLP00000005411 |
| positive regulation of locomotion | ENSAPLP00000013972, ENSAPLP00000005411 |
| regulation of multi-organism process | ENSAPLP00000006303, ENSAPLP00000003050 |
| organelle fission | ENSAPLP00000015963, ENSAPLP00000015503 |
| positive regulation of cell motility | ENSAPLP00000013972, ENSAPLP00000005411 |
| cellular membrane organization | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013090 |
| membrane organization | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013090 |
| lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000009740 |
| M phase of mitotic cell cycle | ENSAPLP00000015963, ENSAPLP00000015503 |
| positive regulation of immune system process | ENSAPLP00000003050, ENSAPLP00000005038 |
| sexual reproduction | ENSAPLP00000011900, ENSAPLP00000011529 |
| monocarboxylic acid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| positive regulation of multicellular organismal process | ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of cellular component movement | ENSAPLP00000013972, ENSAPLP00000005411 |
| epithelium development | ENSAPLP00000003050, ENSAPLP00000008118 |
| DNA conformation change | ENSAPLP00000012216, ENSAPLP00000001720 |
| multicellular organismal process | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| purine nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| glycosyl compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050 |
| response to inorganic substance | ENSAPLP00000003657, ENSAPLP00000006873 |
| regulation of defense response | ENSAPLP00000006303, ENSAPLP00000003050 |
| neurotrophin signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| neurotrophin TRK receptor signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| purine nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| organophosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| nucleoside phosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| regulation of signal transduction | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000004050 |
| response to wounding | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005038 |
| regulation of response to stimulus | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000004050 |
| vesicle-mediated transport | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000015337, ENSAPLP00000005193 |
| carbohydrate derivative catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| regulation of I-kappaB kinase/NF-kappaB cascade | ENSAPLP00000006873, ENSAPLP00000004050 |
| single organism reproductive process | ENSAPLP00000011900, ENSAPLP00000011529 |
| signal transduction | ENSAPLP00000015963, ENSAPLP00000009308, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000009642 |
| regulation of transport | ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| cellular component assembly | ENSAPLP00000015963, ENSAPLP00000003050, ENSAPLP00000006939, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000015503 |
| positive regulation of transport | ENSAPLP00000005411, ENSAPLP00000005038 |
| negative regulation of developmental process | ENSAPLP00000001720, ENSAPLP00000005038 |
| regulation of protein transport | ENSAPLP00000005038, ENSAPLP00000006873 |
| cell division | ENSAPLP00000015963, ENSAPLP00000009642 |
| immune system process | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873 |
| signaling | ENSAPLP00000015963, ENSAPLP00000009308, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000009642 |
| single organism signaling | ENSAPLP00000015963, ENSAPLP00000009308, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000009642 |
| M phase | ENSAPLP00000015963, ENSAPLP00000015503 |
| wound healing | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of system process | ENSAPLP00000003219, ENSAPLP00000013090 |
| regulation of establishment of protein localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of cellular response to stress | ENSAPLP00000005038, ENSAPLP00000006873 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| cellular response to organic substance | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050 |
| GTP catabolic process | ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| guanosine-containing compound catabolic process | ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| response to organic substance | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008118, ENSAPLP00000004050 |
| regulation of cell communication | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000004050 |
| cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| embryo development | ENSAPLP00000003050, ENSAPLP00000003219 |
| chromatin modification | ENSAPLP00000012216, ENSAPLP00000001720 |
| regulation of anatomical structure morphogenesis | ENSAPLP00000003050, ENSAPLP00000013090 |
| organelle organization | ENSAPLP00000003657, ENSAPLP00000015963, ENSAPLP00000012216, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000002381, ENSAPLP00000015503 |
| localization | ENSAPLP00000009308, ENSAPLP00000015337, ENSAPLP00000011711, ENSAPLP00000005193, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000014274, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000011529 |
| cell communication | ENSAPLP00000015963, ENSAPLP00000009308, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000009642 |
| nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| regulation of signaling | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000004050 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| apoptotic process | ENSAPLP00000003657, ENSAPLP00000002381 |
| programmed cell death | ENSAPLP00000003657, ENSAPLP00000002381 |
| negative regulation of apoptotic process | ENSAPLP00000005038, ENSAPLP00000004050 |
| chemical homeostasis | ENSAPLP00000015679, ENSAPLP00000011529 |
| cell surface receptor signaling pathway | ENSAPLP00000015963, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000009642, ENSAPLP00000005038 |
| cellular macromolecular complex assembly | ENSAPLP00000006939, ENSAPLP00000001720, ENSAPLP00000015503 |
| GTP metabolic process | ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| guanosine-containing compound metabolic process | ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| purine-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| glycosyl compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| biological regulation | ENSAPLP00000015963, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090, ENSAPLP00000003050, ENSAPLP00000009642, ENSAPLP00000003219 |
| cell death | ENSAPLP00000003657, ENSAPLP00000002381 |
| death | ENSAPLP00000003657, ENSAPLP00000002381 |
| negative regulation of programmed cell death | ENSAPLP00000005038, ENSAPLP00000004050 |
| positive regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| negative regulation of cell death | ENSAPLP00000005038, ENSAPLP00000004050 |
| ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| ribose phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| regulation of intracellular protein kinase cascade | ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050 |
| regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000013090 |
| transmembrane receptor protein tyrosine kinase signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of protein localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| cellular component biogenesis | ENSAPLP00000015963, ENSAPLP00000003050, ENSAPLP00000006939, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000015503 |
| transport | ENSAPLP00000009308, ENSAPLP00000015337, ENSAPLP00000011711, ENSAPLP00000005193, ENSAPLP00000013090, ENSAPLP00000014274, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000011529 |
| enzyme linked receptor protein signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| response to stress | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050 |
| regulation of cell death | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of apoptotic process | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of programmed cell death | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000004050 |
| establishment of localization | ENSAPLP00000009308, ENSAPLP00000015337, ENSAPLP00000011711, ENSAPLP00000005193, ENSAPLP00000013090, ENSAPLP00000014274, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000011529 |
| chromatin organization | ENSAPLP00000012216, ENSAPLP00000001720 |
| regulation of MAPK cascade | ENSAPLP00000005038, ENSAPLP00000006873 |
| macromolecular complex assembly | ENSAPLP00000006939, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503 |
| regulation of cellular process | ENSAPLP00000015963, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000009308, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090, ENSAPLP00000009642, ENSAPLP00000003050, ENSAPLP00000003219 |
| nucleoside phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| carbohydrate derivative metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| positive regulation of response to stimulus | ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000005038 |
| cell cycle phase | ENSAPLP00000015963, ENSAPLP00000015503 |
| regulation of cellular localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of multicellular organismal development | ENSAPLP00000003050, ENSAPLP00000001720 |
| small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503, ENSAPLP00000009740 |
| regulation of biological process | ENSAPLP00000015963, ENSAPLP00000005193, ENSAPLP00000010816, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090, ENSAPLP00000009642, ENSAPLP00000003050, ENSAPLP00000003219 |
| mitotic cell cycle | ENSAPLP00000015963, ENSAPLP00000015503 |
| small GTPase mediated signal transduction | ENSAPLP00000009308, ENSAPLP00000005193 |
| negative regulation of signal transduction | ENSAPLP00000006303, ENSAPLP00000005038 |
| regulation of cell differentiation | ENSAPLP00000011529, ENSAPLP00000001720 |
| organophosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| macromolecular complex subunit organization | ENSAPLP00000003657, ENSAPLP00000006939, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002381, ENSAPLP00000015503 |
| multi-organism process | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000010584, ENSAPLP00000002381 |
| organonitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| cell cycle | ENSAPLP00000015963, ENSAPLP00000009642, ENSAPLP00000015503 |
| cellular response to stress | ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000006873 |
| single-organism metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503, ENSAPLP00000009740 |
| negative regulation of cellular process | ENSAPLP00000002553, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004050 |
| cellular nitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| heterocycle catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| organic cyclic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| negative regulation of cell communication | ENSAPLP00000006303, ENSAPLP00000005038 |
| negative regulation of signaling | ENSAPLP00000006303, ENSAPLP00000005038 |
| regulation of hydrolase activity | ENSAPLP00000012216, ENSAPLP00000003219 |
| catabolic process | ENSAPLP00000003657, ENSAPLP00000005193, ENSAPLP00000015503, ENSAPLP00000009642, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000009741, ENSAPLP00000009975 |
| regulation of phosphate metabolic process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005038 |
| regulation of phosphorus metabolic process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005038 |
| chromosome organization | ENSAPLP00000012216, ENSAPLP00000001720 |
| protein transport | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000011529, ENSAPLP00000005193, ENSAPLP00000013090 |
| establishment of protein localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000011529, ENSAPLP00000005193, ENSAPLP00000013090 |
| response to endogenous stimulus | ENSAPLP00000003657, ENSAPLP00000008118 |
| regulation of phosphorylation | ENSAPLP00000003050, ENSAPLP00000005038 |
| negative regulation of response to stimulus | ENSAPLP00000006303, ENSAPLP00000005038 |
| cellular catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| organic acid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| protein complex assembly | ENSAPLP00000005038, ENSAPLP00000015503 |
| carboxylic acid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| oxoacid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| positive regulation of cellular process | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050 |
| protein complex subunit organization | ENSAPLP00000003657, ENSAPLP00000005038, ENSAPLP00000002381, ENSAPLP00000015503 |
| protein complex biogenesis | ENSAPLP00000005038, ENSAPLP00000015503 |
| negative regulation of biological process | ENSAPLP00000002553, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004050 |
| single-organism transport | ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000011711, ENSAPLP00000005193, ENSAPLP00000013090 |
| positive regulation of signal transduction | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of cell communication | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of signaling | ENSAPLP00000003050, ENSAPLP00000005038 |
| organic substance catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000011529, ENSAPLP00000009741, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| negative regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000005038 |
| cell cycle process | ENSAPLP00000015963, ENSAPLP00000015503 |
| cellular process | ENSAPLP00000015963, ENSAPLP00000009873, ENSAPLP00000005193, ENSAPLP00000003689, ENSAPLP00000000439, ENSAPLP00000010816, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000009740, ENSAPLP00000006303, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000009975, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000010584, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000009642, ENSAPLP00000003219, ENSAPLP00000009741 |
| intracellular signal transduction | ENSAPLP00000009308, ENSAPLP00000001720, ENSAPLP00000005193 |
| nucleobase-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| DNA metabolic process | ENSAPLP00000012216, ENSAPLP00000001720 |
| positive regulation of catalytic activity | ENSAPLP00000003050, ENSAPLP00000003219 |
| aromatic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| protein localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000011529, ENSAPLP00000005193, ENSAPLP00000013090 |
| organic substance transport | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000011529, ENSAPLP00000005193, ENSAPLP00000013090 |
| regulation of catalytic activity | ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000003219 |
| positive regulation of biological process | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050 |
| positive regulation of protein metabolic process | ENSAPLP00000005038, ENSAPLP00000004050 |
| phosphorus metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| phosphate-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000005193, ENSAPLP00000015503 |
| viral reproduction | ENSAPLP00000006303, ENSAPLP00000003050 |
| multi-organism cellular process | ENSAPLP00000006303, ENSAPLP00000003050 |
| macromolecule localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000011529, ENSAPLP00000005193, ENSAPLP00000013090 |
| positive regulation of molecular function | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of protein metabolic process | ENSAPLP00000012216, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of molecular function | ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000003219 |
| reproductive process | ENSAPLP00000011900, ENSAPLP00000011529 |
| intracellular protein transport | ENSAPLP00000006303, ENSAPLP00000013090 |
| negative regulation of macromolecule metabolic process | ENSAPLP00000002553, ENSAPLP00000005038 |
| negative regulation of metabolic process | ENSAPLP00000002553, ENSAPLP00000005038 |
| cellular localization | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005193, ENSAPLP00000013090 |
| reproduction | ENSAPLP00000011900, ENSAPLP00000011529 |
| positive regulation of metabolic process | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000004050 |
| intracellular transport | ENSAPLP00000006303, ENSAPLP00000005193, ENSAPLP00000013090 |
| regulation of primary metabolic process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000004050 |
| cellular protein localization | ENSAPLP00000006303, ENSAPLP00000013090 |
| cellular macromolecule localization | ENSAPLP00000006303, ENSAPLP00000013090 |
| establishment of localization in cell | ENSAPLP00000006303, ENSAPLP00000005193, ENSAPLP00000013090 |
| positive regulation of cellular metabolic process | ENSAPLP00000005038, ENSAPLP00000004050 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000005038, ENSAPLP00000004050 |
| nucleobase-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| regulation of metabolic process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000004050 |
| cellular aromatic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| heterocycle metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| cellular nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| macromolecule biosynthetic process | ENSAPLP00000010584, ENSAPLP00000011529 |
| cellular macromolecule biosynthetic process | ENSAPLP00000010584, ENSAPLP00000011529 |
| organic cyclic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000009642, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005193, ENSAPLP00000009975, ENSAPLP00000015503 |
| regulation of biosynthetic process | ENSAPLP00000002553, ENSAPLP00000011529, ENSAPLP00000004050 |
| regulation of cellular metabolic process | ENSAPLP00000002553, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005038, ENSAPLP00000004050 |
| cellular biosynthetic process | ENSAPLP00000010584, ENSAPLP00000011529, ENSAPLP00000005038 |
| organic substance biosynthetic process | ENSAPLP00000010584, ENSAPLP00000011529, ENSAPLP00000005038 |
| biosynthetic process | ENSAPLP00000010584, ENSAPLP00000011529, ENSAPLP00000005038 |
| regulation of macromolecule metabolic process | ENSAPLP00000002553, ENSAPLP00000012216, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000004050 |
| cellular metabolic process | ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000010584, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000015503, ENSAPLP00000009740, ENSAPLP00000009642, ENSAPLP00000011529, ENSAPLP00000009741, ENSAPLP00000006873, ENSAPLP00000009975 |
| regulation of cellular biosynthetic process | ENSAPLP00000002553, ENSAPLP00000004050 |
| primary metabolic process | ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000010584, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000015503, ENSAPLP00000009740, ENSAPLP00000009642, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000009741, ENSAPLP00000009975 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000002553, ENSAPLP00000003219 |
| metabolic process | ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000010584, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000015503, ENSAPLP00000009740, ENSAPLP00000009642, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000009741, ENSAPLP00000006873, ENSAPLP00000009975 |
| protein metabolic process | ENSAPLP00000013972, ENSAPLP00000010584, ENSAPLP00000011529, ENSAPLP00000015503 |
| nucleic acid metabolic process | ENSAPLP00000012216, ENSAPLP00000001720 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000002553, ENSAPLP00000003219 |
| regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000005038 |
| organic substance metabolic process | ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000010584, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005193, ENSAPLP00000015503, ENSAPLP00000009740, ENSAPLP00000009642, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000009741, ENSAPLP00000009975 |
| cellular protein metabolic process | ENSAPLP00000010584, ENSAPLP00000015503 |
| macromolecule metabolic process | ENSAPLP00000013972, ENSAPLP00000012216, ENSAPLP00000010584, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000015503 |
| cellular macromolecule metabolic process | ENSAPLP00000012216, ENSAPLP00000010584, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000015503 |
|